Trial Profile
Intrapulmonary laninamivir pharmacokinetics and intracellular disposition following a single inhalation in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2013
Price :
$35
*
At a glance
- Drugs Laninamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 06 Nov 2013 New trial record